Oncocyte Corp. Files SEC Form 8-K, Current Report: (Oct. 15, 2024).

Oncocyte Corp. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 15, 2024. The filing pertains to material events or corporate changes important to investors and provides current information not previously reported. The company's SIC code is 2835, and the filing can be accessed on the SEC's website. This news article focuses on business, SEC filings, and healthcare biotechnology companies. [Extracted from the article]